Commentary: Is Faecalibacterium prausnitzii a potential treatment for maintaining remission in ulcerative colitis?

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 5, 2013, Pages 551-

  Siaw, Y H ^a   Hart, A ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; FRUCTOSE OLIGOSACCHARIDE; INULIN; PROBIOTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; BIOCHEMICAL COMPOSITION; CROHN DISEASE; FAECALIBACTERIUM PRAUSNITZII; HUMAN; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REMISSION; TREATMENT RESPONSE; ULCERATIVE COLITIS;

EID: 84882425184     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12404     Document Type: Note

References (7)

1. Varela E, Manichanh C, Gallart M, et al,. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Aliment Pharmacol Ther 2013; 38: 151-61.
2. Sokol H, Seksik P, Furet JP, et al,. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009; 15: 1183-9.
3. Sokol H, Pigneur B, Watterlot L, et al,. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105: 16731-6.
4. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P,. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 2009; 101: 541-50.
5. Benjamin JL, Hedin CRH, Koutsoumpas A, et al,. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut 2011; 60: 923-9.
6. Benus RFJ, van der Werf TS, Welling GW, et al,. Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br J Nutr 2010; 104: 693-700.
7. Joossens M, Huys G, Cnockaert M, et al,. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011; 60: 631-7.